Western Blotting Market Size by Product, Application, End-Users and Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2032
Overview
The Western Blotting Market size was valued at USD 1.23 Billion in 2024 and the total Western Blotting revenue is expected to grow at a CAGR of 6.8% from 2025 to 2032, reaching nearly USD 2.09 Billion.
Western Blotting Market Overview:
In fundamental cell biology research, drug development, and disease, the Western blot is the most commonly used analytical method to examine molecular function. The technical aspects of western blotting have improved significantly, resulting in increased efficiency, repeatability, and ease of use.
To know about the Research Methodology :- Request Free Sample Report
Western Blotting Market Dynamics:
Rising demand for personalized medicine is the major factor driving the market growth
Factors such as the rising global burden of chronic diseases, growing research activities in the biotech and pharma sector, and increased R&D investment by pharmaceutical and biotechnology businesses are driving the western blotting market. Over the forecast period, the global western blotting market is expected to grow due to the rising prevalence of HIV/AIDS. For example, the Joint United Nations Program on HIV/AIDS estimates that 37.9 million individuals worldwide were living with HIV at the end of 2018. Furthermore, rising applications of the western blotting technique are likely to drive market growth. In January 2020, researchers from the British Antarctic Survey and the Natural Environment Research Council in the United Kingdom reported using western blotting to analyse post-translationally deiminated protein and EV profiles of plasma in Antarctic seabird species.
When compared to other immunosorbent assays (ISAs), such as ELISA, the Western blotting or immunoblotting approach provides a number of advantages. Western blotting is a more advanced approach than ELISA since it allows for the separation of protein mixtures based on charge, size, and/or conformation. With western blotting, this method of stripping can be used to detect many targets, whereas in ELISA, only one protein can be detected. The size of the target protein can be evaluated using this technique because gel electophoreis of proteins aids in the separation of proteins into bands. The emergence of alternative technologies is projected to stifle market growth. AlphaScreen technology, for example, is a new and very sensitive homogeneous bead-based platform for the identification of biomolecules. The method eliminates the need for time-consuming wash procedures and detects any molecule of interest, primarily from protein complexes. Furthermore, the western blot approach is a semi-quantitative procedure that can only provide an estimate. This flaw is also predicted to the hamper market growth.
The report has profiled sixteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Western Blotting Market Segment Analysis:
The Global Western Blotting Market is segmented on the basis of Product, Application and End-Users.
Based on Product, the Consumables segment accounted for dominant market share in 2024. Because of the increased prevalence of target diseases that necessitate western blotting for research and diagnosis, consumables led the market in 2024. Western blotting techniques make extensive use of these products.
Based on Application, the disease diagnostic segment is expected to hold a dominant market share during the forecast period. In medical diagnostics, the Western blot test has a wide range of applications. BSE (Bovine Spongiform Encephalopathy), FIV (Feline Immunodeficiency Virus), HBV (Hepatitis B Virus) infection, Lyme disease, and other disorders can all be diagnosed with this test. In medical diagnostics, the Western blot test has a wide range of applications. This test is typically used as a follow-up to an ELISA test that has yielded a positive result for the disorders listed above. The US FDA has recommended a two-tier strategy for Lyme disease, with an ELISA test first and then a specific western blot test for confirmation of diagnosis if the ELISA findings are positive. Western blotting was once the standard method for confirming an HIV diagnosis. The Centres for Disease Control and Prevention (CDC) suggested that the Western blot test for HIV be phased out this year because new HIV detection techniques have emerged on the market.
Western Blotting Market Regional Insights:
North America is expected to dominate the global market.
The North American region dominates the global market for western blotting, with the United States accounting for the greatest share. The sophisticated healthcare system and the presence of important players in the country are the primary factors leading to the large share in the United States. Companies such as Bio-Rad, Thermo Fisher Scientific and others are active in the US market, and due to the adaptable nature of the US population to novel products or technologies, companies are able to launch novel product launches in the US, which is assisting the market studied to grow in this region.
The report also helps in understanding Global Western Blotting Market dynamics, structure by analyzing the market segments and project the Global Western Blotting Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Western Blotting Market make the report investor’s guide.
Western Blotting Market Scope: Inquire before buying
| Western Blotting Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2024 | Forecast Period: | 2025-2032 |
| Historical Data: | 2019 to 2024 | Market Size in 2024: | USD 1.23 Bn. |
| Forecast Period 2025 to 2032 CAGR: | 6.8% | Market Size in 2032: | USD 2.09 Bn. |
| Segments Covered: | by Product | Gel Electrophoresis Blotting Systems Imagers Consumables |
|
| by Application | Biomedical & Biochemical Research Disease Diagnostics Others |
||
| by End-Users | Academia and Research Institutes Diagnostic Centers Others |
||
Western Blotting Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Western Blotting Market, Key players
1. Thermo Fisher Scientific, Inc.
2. Bio-Rad Laboratories, Inc.
3. LI-COR Biosciences
4. F. Hoffmann-La Roche Ltd.
5. Bio-Techne Corporation
6. GE Healthcare
7. Merck KGaA
8. PerkinElmer, Inc.
9. Advansta, Inc.
10.Cell Signaling Technology
11.DANAHER
12.Amicon ultra (EMD Millipore Corporation)
13.Emagin Corporation
14.Azure Biosystems, Inc.
15.Cygnus Technologies
16.KOMABIOTECH
Frequently Asked Questions:
1. Which region has the largest share in Global Western Blotting Market?
Ans: North America region holds the highest share in 2024.
2. What was the Global Western Blotting Market size in 2024?
Ans: The Global Western Blotting Market size was USD 1.23 Billion in 2024.
3. What is scope of the Global Western Blotting market report?
Ans: Global Western Blotting Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Western Blotting market?
Ans: The important key players in the Global Western Blotting Market are – Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., LI-COR Biosciences, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, GE Healthcare, Merck KGaA, PerkinElmer, Inc., Advansta, Inc., Cell Signaling Technology, DANAHER, Amicon ultra (EMD Millipore Corporation), Emagin Corporation, Azure Biosystems, Inc., and Cygnus Technologies.
5. What is the study period of this market?
Ans: The Global Market is studied from 2024 to 2032.